FDA criticises trial of GSK diabetes drug
Health / Medicine Related News
The US regulator has condemned the pharmaceutical group's pivotal clinical trial as 'inadequately designed and conducted to provide any reassurance about the [cardio-vascular] safety' of Avandia
Source: FT.com - Pharmaceuticals